Test your knowledge about venetoclax

How long is venetoclax typically administered in the relapsed setting in patients with CLL?  
6 months 
1 year 
2 years 
3 years 
Which of the following is NOT a key adverse event that can be seen with venetoclax-based regimens?
Neutropenia 
Infections 
Tumor lysis syndrome 
Atrial fibrillation 
When compared to each other in combination with venetoclax, which of the following anti-CD20 monoclonal antibodies is associated with improved PFS & higher levels of uMRD at month 15 of treatment in frontline CLL? 
Rituximab 
Obinutuzumab 
{"name":"Test your knowledge about venetoclax", "url":"https://www.quiz-maker.com/QD50YT364","txt":"How long is venetoclax typically administered in the relapsed setting in patients with CLL?, Which of the following is NOT a key adverse event that can be seen with venetoclax-based regimens?, When compared to each other in combination with venetoclax, which of the following anti-CD20 monoclonal antibodies is associated with improved PFS & higher levels of uMRD at month 15 of treatment in frontline CLL?","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}